欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
NL/H/4762/002
药品名称
Cefuroxim Fresenius Kabi 1500 mg, poeder voor oplossing voor injectie/infusie
活性成分
cefuroxime 1500.0 mg
剂型
Powder for solution for injection
上市许可持有人
Fresenius Kabi Nederland B.V. Amersfoortseweg 10E 3712 BC Huis ter Heide Nederland
参考成员国 - 产品名称
Netherlands (NL)
互认成员国 - 产品名称
Denmark (DK)
Cefuroxime Yes
Belgium (BE)
United Kingdom (Northern Ireland) (XI)
Ireland (IE)
Greece (GR)
Norway (NO)
Poland (PL)
Hungary (HU)
CEFUROXIM KABI 1500 mg por oldatos injekcióhoz
Czechia (CZ)
Cefuroxim YES 1,5 g
Slovakia (SK)
Cefuroxim YES 1500 mg
Iceland (IS)
许可日期
2008/11/27
最近更新日期
2024/05/23
药物ATC编码
J01DC02 cefuroxime
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final Product Information
|
common_outer_1500mg_nl4762_02_ib_020_clean
Date of last change:2024/09/06
Final Product Information
|
common_pl_1500mg_nl4762_02_ib_020_clean
Date of last change:2024/09/06
Final Product Information
|
common_spc_1500mg_nl4762_02_ib_020_clean
Date of last change:2024/09/06
PubAR
|
PAR 4762_Cefuroxim Fresenius 750 _1500mg_20 February 2023
Date of last change:2024/09/06
PubAR Summary
|
sPAR 4762_Cefuroxim Fresenius 750 _1500mg_EN_20 February 2023
Date of last change:2024/09/06
Final Labelling
|
DE912_Cefuroxim_common_impack_1500mg_clean_20131010_renewal
Date of last change:2024/09/06
Final Labelling
|
DE912_Cefuroxim_common_impack_750mg_clean_20131010_renewal
Date of last change:2024/09/06
Final Labelling
|
DE912_Cefuroxim_common_outer_1500mg_clean_20131010_renewal
Date of last change:2024/09/06
Final Labelling
|
DE912_Cefuroxim_common_outer_750mg_clean_20131010_renewal
Date of last change:2024/09/06
Final PL
|
DE912_Cefuroxim_common_pl_1500mg_clean_20131010_renewal
Date of last change:2024/09/06
Final PL
|
DE912_Cefuroxim_common_pl_750mg_clean_20131010_renewal
Date of last change:2024/09/06
Final SPC
|
DE912_Cefuroxim_common_spc_1500mg_clean_20131010_renewal
Date of last change:2024/09/06
Final SPC
|
DE912_Cefuroxim_common_spc_750mg_clean_20131010_renewal
Date of last change:2024/09/06
Final Labelling
|
DE913_Cefuroxim_common_impack_750mg_clean_20131010_renewal
Date of last change:2024/09/06
Final Labelling
|
DE913_Cefuroxim_common_outer_750mg_clean_20131010_renewal
Date of last change:2024/09/06
Final PL
|
DE913_Cefuroxim_common_pl_750mg_clean_20131010_renewal
Date of last change:2024/09/06
Final SPC
|
DE913_Cefuroxim_common_spc_750mg_clean_20131010_renewal
Date of last change:2024/09/06
Final Labelling
|
DE914_Cefuroxim_common_impack_1500mg_clean_20131010_renewal
Date of last change:2024/09/06
Final Labelling
|
DE914_Cefuroxim_common_outer_1500mg_clean_20131010_renewal
Date of last change:2024/09/06
Final PL
|
DE914_Cefuroxim_common_pl_1500mg_clean_20131010_renewal
Date of last change:2024/09/06
Final SPC
|
DE914_Cefuroxim_common_spc_1500mg_clean_20131010_renewal
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase